APSF News & Updates
Glucagon-Like Peptide-1 Receptor Agonist Medications and Nonarteritic Ischemic Optic Neuropathy: Is there cause for concern?
April 28, 2025
Nonarteritic ischemic optic neuropathy (NAION) is associated with ischemia of the optic nerve and is a leading cause of vision loss, especially in patients older than 50 years. The condition…
Patient Safety Alert: Urgent Alert Regarding Medication Vial Coring and Fragmentation Risks
March 30, 2025
Issued by: Anesthesia Patient Safety Foundation (APSF) and ECRI/Institute for Safe Medication Practices (ISMP) APSF and ECRI/ISMP have received several reports recently of medication vial coring incidents. Coring occurs when…
PDF
APSF Recognizes the 23 Institutions That Submitted Letters of Intent for Research Projects
March 14, 2025
Grant programs administered jointly by APSF and the Foundation for Anesthesia Education and Research (FAER) received 34 Letters of Intent from 21 institutions across the United States and Canada during the 2025-2026 funding cycle…
Concerns regarding Sugammadex Use During Pregnancy and Lactation
March 12, 2025
We reach out with utmost respect to the Anesthesia Patient Safety Foundation (APSF) in response to the article “Safety of Sugammadex in Pregnancy, Pediatrics, and Renal Failure.” While we understand…
APSF Newsletter – February 2025
February 1, 2025
The Anesthesia Patient Safety Foundation is pleased to announce the release of the February 2025 APSF Newsletter.
